Gaush Meditech Statistics
Total Valuation
Gaush Meditech has a market cap or net worth of EUR 99.91 million. The enterprise value is 105.43 million.
Market Cap | 99.91M |
Enterprise Value | 105.43M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
Earnings Date | Aug 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 146.67M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.14% |
Shares Change (QoQ) | -0.20% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 51.41M |
Valuation Ratios
The trailing PE ratio is 8.17.
PE Ratio | 8.17 |
Forward PE | n/a |
PS Ratio | 0.53 |
PB Ratio | 0.48 |
P/TBV Ratio | 2.04 |
P/FCF Ratio | 8.11 |
P/OCF Ratio | 7.00 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.59, with an EV/FCF ratio of 8.56.
EV / Earnings | 8.62 |
EV / Sales | 0.62 |
EV / EBITDA | 3.59 |
EV / EBIT | 5.34 |
EV / FCF | 8.56 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.35.
Current Ratio | 2.25 |
Quick Ratio | 1.34 |
Debt / Equity | 0.35 |
Debt / EBITDA | 2.24 |
Debt / FCF | 5.93 |
Interest Coverage | 4.51 |
Financial Efficiency
Return on equity (ROE) is 5.39% and return on invested capital (ROIC) is 4.60%.
Return on Equity (ROE) | 5.39% |
Return on Assets (ROA) | 3.83% |
Return on Invested Capital (ROIC) | 4.60% |
Return on Capital Employed (ROCE) | 8.06% |
Revenue Per Employee | 213,826 |
Profits Per Employee | 13,831 |
Employee Count | 884 |
Asset Turnover | 0.53 |
Inventory Turnover | 2.34 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.63% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -68.63% |
50-Day Moving Average | 0.65 |
200-Day Moving Average | 1.01 |
Relative Strength Index (RSI) | 48.47 |
Average Volume (20 Days) | 1,360 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gaush Meditech had revenue of EUR 189.02 million and earned 12.23 million in profits. Earnings per share was 0.08.
Revenue | 189.02M |
Gross Profit | 86.54M |
Operating Income | 21.91M |
Pretax Income | 20.55M |
Net Income | 12.23M |
EBITDA | 29.47M |
EBIT | 21.91M |
Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 68.68 million in cash and 73.08 million in debt, giving a net cash position of -4.40 million.
Cash & Cash Equivalents | 68.68M |
Total Debt | 73.08M |
Net Cash | -4.40M |
Net Cash Per Share | n/a |
Equity (Book Value) | 210.17M |
Book Value Per Share | 1.42 |
Working Capital | 84.55M |
Cash Flow
In the last 12 months, operating cash flow was 14.26 million and capital expenditures -1.94 million, giving a free cash flow of 12.32 million.
Operating Cash Flow | 14.26M |
Capital Expenditures | -1.94M |
Free Cash Flow | 12.32M |
FCF Per Share | n/a |
Margins
Gross margin is 45.78%, with operating and profit margins of 11.59% and 6.47%.
Gross Margin | 45.78% |
Operating Margin | 11.59% |
Pretax Margin | 10.87% |
Profit Margin | 6.47% |
EBITDA Margin | 15.59% |
EBIT Margin | 11.59% |
FCF Margin | 6.52% |
Dividends & Yields
Gaush Meditech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 160.78% |
Buyback Yield | 0.14% |
Shareholder Yield | n/a |
Earnings Yield | 12.24% |
FCF Yield | 12.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Gaush Meditech has an Altman Z-Score of 3.34.
Altman Z-Score | 3.34 |
Piotroski F-Score | n/a |